{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T01:32:29Z","timestamp":1788312749013,"version":"build-2803163510"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2022,10,31]],"date-time":"2022-10-31T00:00:00Z","timestamp":1667174400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,10,31]],"date-time":"2022-10-31T00:00:00Z","timestamp":1667174400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Intervent Radiol"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1007\/s00270-022-03289-7","type":"journal-article","created":{"date-parts":[[2022,10,31]],"date-time":"2022-10-31T22:02:46Z","timestamp":1667253766000},"page":"590-597","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Comparison Between Clinical Outcomes of Low- and High-Dose Paclitaxel Drug-Coated Balloon in Endovascular Therapy for Femoropopliteal Lesion"],"prefix":"10.1007","volume":"46","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9037-867X","authenticated-orcid":false,"given":"Shinsuke","family":"Mori","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasutaka","family":"Yamauchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuki","family":"Doijiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuki","family":"Tobita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiichi","family":"Hishikari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yohsuke","family":"Honda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masakazu","family":"Tsutsumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norihiro","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Yamawaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiaki","family":"Ito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,10,31]]},"reference":[{"key":"3289_CR1","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1093\/eurheartj\/ehx095","volume":"39","author":"V Aboyans","year":"2018","unstructured":"Aboyans V, Ricco JB, Bartelink MEL, Bj\u00f6rck M, Brodmann M, Cohnert T, et al. ESC Guidelines on the diagnosis and treatment of peripheral arterial diseases, in collaboration with the European society for vascular surgery (ESVS): document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries endorsed by: the European stroke organization (ESO) The Task Force for the diagnosis and treatment of peripheral arterial diseases of the European society of cardiology (ESC) and of the European society for vascular surgery (ESVS). Eur Heart J. 2018;39:763\u2013816.","journal-title":"Eur Heart J"},{"key":"3289_CR2","doi-asserted-by":"publisher","first-page":"1879","DOI":"10.1056\/NEJMoa051303","volume":"354","author":"M Schillinger","year":"2006","unstructured":"Schillinger M, Sabeti S, Loewe C, Dick P, Amighi J, Mlekusch W, et al. Balloon angioplasty versus implantation of nitinol stents in the superficial femoral artery. N Engl J Med. 2006;354:1879\u201388.","journal-title":"N Engl J Med"},{"key":"3289_CR3","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1161\/CIRCINTERVENTIONS.111.962324","volume":"4","author":"MD Dake","year":"2011","unstructured":"Dake MD, Ansel GM, Jaff MR, Ohki T, Saxon RR, Smouse HB, et al. Paclitaxel-eluting stents show superiority to balloon angioplasty and bare metal stents in femoropopliteal disease: twelve-month zilver PTX randomized study results. Circ Cardiovasc Interv. 2011;4:495\u2013504.","journal-title":"Circ Cardiovasc Interv"},{"key":"3289_CR4","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.jacc.2011.09.036","volume":"59","author":"A Tosaka","year":"2012","unstructured":"Tosaka A, Soga Y, Iida O, Ishihara T, Hirano K, Suzuki K, et al. Classification and clinical impact of restenosis after femoropopliteal stenting. J Am Coll Cardiol. 2012;59:16\u201323.","journal-title":"J Am Coll Cardiol"},{"key":"3289_CR5","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCINTERVENTIONS.115.002730","volume":"9","author":"S Banerjee","year":"2016","unstructured":"Banerjee S, Sarode K, Mohammad A, Gigliotti O, Baig MS, Tsai S, et al. Femoropopliteal artery stent thrombosis: report from the excellence in peripheral artery disease registry. Circ Cardiovasc Interv. 2016;9: e002730.","journal-title":"Circ Cardiovasc Interv"},{"key":"3289_CR6","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1056\/NEJMoa0706356","volume":"358","author":"G Tepe","year":"2008","unstructured":"Tepe G, Zeller T, Albrecht T, Heller S, Schwarzw\u00e4lder U, Beregi JP, et al. Local delivery of paclitaxel to inhibit restenosis during angioplasty of the leg. N Engl J Med. 2008;358:689\u201399.","journal-title":"N Engl J Med"},{"key":"3289_CR7","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.jcin.2013.05.022","volume":"7","author":"D Sheinert","year":"2014","unstructured":"Sheinert D, Duda S, Zeller T, Krankenberg H, Ricke J, Bosiers M, et al. The LEVANT I (Lutonix paclitaxel-coated balloon for the prevention of femoropopliteal restenosis) trial for femoropopliteal revascularization: first-in-human randomized trial of low-dose drug-coated balloon versus uncoated balloon angioplasty. JACC Cardiocasc Interv. 2014;7:10\u20139.","journal-title":"JACC Cardiocasc Interv"},{"key":"3289_CR8","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1161\/CIRCULATIONAHA.114.011004","volume":"131","author":"G Tepe","year":"2015","unstructured":"Tepe G, Laird J, Schneider P, Brodmann M, Krishnan P, Micari A, et al. Drug-coated balloon versus standard percutaneous transluminal angioplasty for the treatment of superficial femoral and popliteal peripheral artery disease: 12-month results from the IN.PACT SFA randomized trial. Circulation. 2015;131:495\u2013502.","journal-title":"Circulation"},{"key":"3289_CR9","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1002\/ccd.27635","volume":"92","author":"DN Feldman","year":"2018","unstructured":"Feldman DN, Armstrong EJ, Aronow HD, Gigliotti OS, Jaff MR, Klein AJ, et al. SCAI consensus guidelines for device selection in femoral-popliteal arterial interventions. Catheter Cardiovasc Interv. 2018;92:124\u201340.","journal-title":"Catheter Cardiovasc Interv"},{"key":"3289_CR10","doi-asserted-by":"publisher","first-page":"2541","DOI":"10.1093\/eurheartj\/ehaa049","volume":"41","author":"S Steiner","year":"2020","unstructured":"Steiner S, Schmidt A, Zeller T, Tepe G, Thieme M, Maiwald L, et al. COMPARE: prospective, randomized, non-inferiority trial of high- vs. low-dose paclitaxel drug-coated balloons for femoropopliteal interventions. Eur Heart J. 2020;41:2541\u201352.","journal-title":"Eur Heart J."},{"key":"3289_CR11","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1016\/j.ejvs.2018.11.019","volume":"57","author":"A Boitet","year":"2019","unstructured":"Boitet A, Grassin-Delyle S, Louedec L, Dupont S, Lamy E, Coggia M, et al. An experimental study of paclitaxel embolisation during drug coated balloon angioplasty. Eur J Vasc Endovasc Surg. 2019;57:578\u201386.","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"3289_CR12","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1177\/1526602816656612","volume":"23","author":"S Okuno","year":"2016","unstructured":"Okuno S, Iida O, Shiraki T, Fujita M, Masuda M, Okamoto S, et al. Impact of calcification on clinical outcomes after endovascular therapy for superficial femoral artery disease: assessment using the peripheral artery calcification scoring system. J Endovasc Ther. 2016;23:731\u20137.","journal-title":"J Endovasc Ther"},{"key":"3289_CR13","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1016\/j.jvs.2011.03.286","volume":"54","author":"Y Soga","year":"2011","unstructured":"Soga Y, Iida O, Hirano K, Suzuki K, Tosaka A, Yokoi H, et al. Utility of new classification based on clinical and lesional factors after self-expandable nitinol stenting in the superficial femoral artery. J Vasc Surg. 2011;54:1058\u201366.","journal-title":"J Vasc Surg"},{"key":"3289_CR14","first-page":"493","volume":"16","author":"JH Rogers","year":"2004","unstructured":"Rogers JH, Lasala JM. Coronary artery dissection and perforation complicating percutaneous coronary intervention. J Invasive Cardiol. 2004;16:493\u20139.","journal-title":"J Invasive Cardiol"},{"key":"3289_CR15","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1002\/pst.433","volume":"10","author":"PC Austin","year":"2011","unstructured":"Austin PC. Optimal caliper widths for propensity-score matching when estimating differences in means and differences in proportions in observational studies. Pharm Stat. 2011;10:150\u201361.","journal-title":"Pharm Stat"},{"key":"3289_CR16","doi-asserted-by":"crossref","unstructured":"Steiner S, Willfort-Ehringer A, Sievert H, Geist V, Lichtenberg M, Giudice CD et al. Ranger SFA investigators. 12-month Results from the first-in-human randomized study of the ranger paclitaxel-coated balloon for femoropopliteal treatment. JACC: Cardiocasc Interv. 2018;11:934\u201341","DOI":"10.1016\/j.jcin.2018.01.276"},{"key":"3289_CR17","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1161\/CIRCULATIONAHA.117.028893","volume":"136","author":"P Krishnan","year":"2017","unstructured":"Krishnan P, Faries P, Niazi K, Jain A, Sachar R, Bachinsky WB, et al. Stella rex drug-coated balloon for treatment of femoropopliteal disease: twelve-month outcome from the randomized ILLUMENATE pivotal and pharmacokinetic studies. Circulation. 2017;136:1102\u201313.","journal-title":"Circulation"},{"key":"3289_CR18","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1016\/j.jcin.2015.03.020","volume":"8","author":"CA Gongora","year":"2015","unstructured":"Gongora CA, Shibuya M, Wessler JD, McGregor J, Tellez A, Cheng Y, et al. Impact of paclitaxel dose on tissue pharmacokinetics and vascular healing: a comparative drug-coated balloon study in the familial hypercholesterolemic swine model of superficial femoral in-stent restenosis. JACC Cardiovasc Interv. 2015;8:1115\u201323.","journal-title":"JACC Cardiovasc Interv"},{"issue":"10","key":"3289_CR19","doi-asserted-by":"publisher","first-page":"17220","DOI":"10.1038\/s41598-020-74227-1","volume":"14","author":"A Heinrich","year":"2020","unstructured":"Heinrich A, Engler MS, Guttler FV, Matthaus C, Popp J, Teichgraber KM. Systematic evaluation of particle loss during handling in the percutaneous transluminal angioplasty for eight different drug-coated balloons. Sci Rep. 2020;14(10):17220.","journal-title":"Sci Rep"},{"key":"3289_CR20","doi-asserted-by":"publisher","first-page":"1682","DOI":"10.1016\/j.jcin.2017.04.041","volume":"10","author":"M Thieme","year":"2017","unstructured":"Thieme M, von Bilderling P, Paetzel C, Karnabatidis D, Delgado JP, Lichtenberg M. The 24-month results of the Lutonix global SFA Registry. JACC Cardiocasc Interv. 2017;10:1682\u201390.","journal-title":"JACC Cardiocasc Interv"},{"key":"3289_CR21","doi-asserted-by":"publisher","first-page":"2329","DOI":"10.1016\/j.jacc.2015.09.063","volume":"66","author":"JR Laird","year":"2015","unstructured":"Laird JR, Schneider PA, Tepe G, Brodmann M, Zeller T, Metzger C, et al. Durability of treatment effect using a drug-coated balloon for femoropopliteal lesions: 24-month results of IN.PACT SFA. J Am Coll Cardiol. 2015;66:2329\u201338.","journal-title":"J Am Coll Cardiol."},{"key":"3289_CR22","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1056\/NEJMoa1406235","volume":"373","author":"K Rosenfield","year":"2015","unstructured":"Rosenfield K, Jaff MR, White CJ, Rocha-Singh K, Mena-Hurtado C, Metzger DC, et al. Trial of a paclitaxel-coated balloon for femoropopliteal artery disease. N Engl J Med. 2015;373:145\u201353.","journal-title":"N Engl J Med"},{"key":"3289_CR23","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1016\/j.jcin.2018.02.019","volume":"11","author":"A Micari","year":"2018","unstructured":"Micari A, Brodmann M, Keirse K, Peeters P, Tepe G, Frost M, et al. Drug-coated balloon treatment of femoropopliteal lesions for patients with intermittent claudication and ischemic rest pain: 2-year results from the IN.PACT global study. JACC Cardiovasc Interv. 2018;11:945\u201353.","journal-title":"JACC Cardiovasc Interv"},{"key":"3289_CR24","doi-asserted-by":"publisher","first-page":"1476","DOI":"10.1007\/s00380-015-0740-7","volume":"31","author":"M Fujihara","year":"2016","unstructured":"Fujihara M, Higashimori A, Kato Y, Taniguchi H, Iwasaki Y, Amano T, et al. Nitinol stent implantation for femoropopliteal disease in patients on hemodialysis: results of the 3-year retrospective multicenter APOLLON study. Heart Vessel. 2016;31:1476\u201383.","journal-title":"Heart Vessel"},{"key":"3289_CR25","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1186\/s12872-020-01805-6","volume":"20","author":"M Takahara","year":"2020","unstructured":"Takahara M, Soga Y, Fujihara M, Kawasaki D, Kozuki A, Iida O. Inverse association of diabetes and dialysis with the severity of the femoropopliteal lesions and chronic total occlusion: a cross-sectional study of 2056 cases. BMC Cardiovasc Disord. 2020;20:514.","journal-title":"BMC Cardiovasc Disord"},{"key":"3289_CR26","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1016\/j.jcin.2016.04.012","volume":"9","author":"CM Kinstner","year":"2016","unstructured":"Kinstner CM, Lammer J, Willfort-Ehringer A, Matzek W, Gschwandtner M, Javor D, et al. Paclitaxel-eluting balloon versus standard balloon angioplasty in-stent restenosis of the superficial femoral and proximal popliteal artery: 1-year results of the PACUBA trial. JACC Cardiovasc Interv. 2016;9:1386\u201392.","journal-title":"JACC Cardiovasc Interv"},{"key":"3289_CR27","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/j.jcin.2013.11.020","volume":"7","author":"V Virga","year":"2014","unstructured":"Virga V, Stabile E, Biamino G, Salemme L, Cioppa A, Giugliano G, et al. Drug-eluting balloons for the treatment of the superficial femoral artery in-stent restenosis: 2-year follow-up. JACC Cardiovasc Interv. 2014;7:411\u20135.","journal-title":"JACC Cardiovasc Interv"},{"issue":"4","key":"3289_CR28","first-page":"508","volume":"58","author":"JC Van Den Berg","year":"2017","unstructured":"Van Den Berg JC. IN-stent restenosis management: the best is yet to come. J Cardiovasc Surg. 2017;58(4):508\u201317.","journal-title":"J Cardiovasc Surg"},{"key":"3289_CR29","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.jcin.2012.09.011","volume":"6","author":"D Scheinert","year":"2013","unstructured":"Scheinert D, Werner M, Scheinert S, Paetzold A, Banning-Eichenseer U, Piorkowski M, et al. Treatment of complex atherosclerotic popliteal artery disease with a new self-expanding interwoven nitinol stent: 12-month results of the Leipzig SUPERA popliteal artery stent registry. JACC Cardiovasc Interv. 2013;6:65\u201371.","journal-title":"JACC Cardiovasc Interv"},{"key":"3289_CR30","doi-asserted-by":"publisher","first-page":"1690","DOI":"10.1016\/j.jvs.2016.12.128","volume":"65","author":"S Hiramori","year":"2017","unstructured":"Hiramori S, Soga Y, Iida O, Suzuki K, Hirano K, Kawasaki D, et al. Relationship between clinical outcomes and vessel size in endovascular therapy for femoropopliteal lesions. J Vasc Surg. 2017;65:1690\u20137.","journal-title":"J Vasc Surg"},{"key":"3289_CR31","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1177\/15266028211058683","volume":"29","author":"K Horie","year":"2022","unstructured":"Horie K, Tanaka A, Taguri M, Inoue N. Impact of baseline and postprocedural intravascular ultrasound findings on 1-year primary patency after drug-coated balloon treatment of femoropopliteal lesions. J Endovasc Ther. 2022;29:66\u201375.","journal-title":"J Endovasc Ther"},{"key":"3289_CR32","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1016\/j.jvs.2011.10.106","volume":"55","author":"JJ Lee","year":"2012","unstructured":"Lee JJ, Katz SG. The number of patent tibial vessels does not influence primary patency after nitinol stenting of the femoral and popliteal arteries. J Vasc Surg. 2012;55:994\u20131000.","journal-title":"J Vasc Surg"}],"container-title":["CardioVascular and Interventional Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00270-022-03289-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00270-022-03289-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00270-022-03289-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,4]],"date-time":"2023-05-04T03:28:30Z","timestamp":1683170910000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00270-022-03289-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,31]]},"references-count":32,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,5]]}},"alternative-id":["3289"],"URL":"https:\/\/doi.org\/10.1007\/s00270-022-03289-7","relation":{},"ISSN":["0174-1551","1432-086X"],"issn-type":[{"value":"0174-1551","type":"print"},{"value":"1432-086X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,31]]},"assertion":[{"value":"10 April 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 September 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 October 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Kazuki Tobita reports remuneration for lecture at Medtronic. All other authors report no conflict of interest","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"Approval was obtained from the local ethics committee. All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed Consent"}},{"value":"Consent for publication was obtained for every individual person\u2019s data included in the study.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}}]}}